Research Article

Related GMR Articles

Cardiac function; Interventional treatment; Myocardial infarction; Myocardial perfusion; Platelet alpha-granule membrane protein; Tirofiban

This study aimed to investigate the effect of intracoronary application of tirofiban on platelet alpha-granule membrane protein (GMP-140) and myocardial perfusion levels during emergency percutaneous coronary intervention (PCI). A total of 70 patients who accepted emergency PCI treatment were randomly divided into tirofiban and control groups. We determined GMP-140 and troponin I (cTnI) ... more

H.P. Xu; C.M. Liu; W.W. Zhang
Cardiovascular disease; Meta-analysis; Myocardial infarction; Visfatin

Visfatin, an adipocytokine involved in metabolic and immune disorders, plays an important role in the etiology of cardiovascular disease. Recent evidence has shown that an elevated plasma level of visfatin may increase the risk of myocardial infarction (MI), but individual published studies have shown inconclusive results. This study aimed to obtain a more precise estimate of the ... more

Y. Yang; Z. Li; H.F. Tao; X.Y. Qi; W.L. Wang; L. Yang; H. Wang; P. Xu
Genetic polymorphisms; Myocardial infarction; Serum amyloid A

Previous studies suggested that genetic polymorphisms of serum amyloid A (SAA) were associated with carotid atherosclerosis. However, the relationship between genetic polymorphisms of SAA and myocardial infarction (MI) remains unclear. In the present study, we analyzed a polymorphism (rs12218) in the SAA1 gene in 840 MI patients and 840 healthy subjects by polymerase chain ... more

B.Y. Wang; J.Y. Hang; Y. Zhong; S.J. Tan
Echocardiography; Myocardial infarction; Recombinant human brain natriuretic peptide; Three-dimensional speckle tracking imaging technology; Ventricular function

Three-dimensional ultrasound speckle tracking imaging was used to evaluate the effects of recombinant human brain natriuretic peptide (rhBNP) in acute anterior and extensive anterior myocardial infarction. Ninety patients with acute anterior or extensive myocardial infarction were randomly divided into 3 groups: Group A [emergency percutaneous coronary intervention (PCI)], Group B (emergency ... more

Y. Zhang; F. Gao; X.Y. Zhang; Y.M. Hou; Y. Tang; S.L. Yang; S.H. Zhu; R.Y. Luo; S.F. Lin
Angiotensinogen; Gene polymorphism; Meta-analysis; Myocardial infarction

Numerous studies have evaluated the association between the T174M polymorphism in the angiotensinogen (AGT) gene and myocardial infarction (MI) risk. However, the specific association remains controversial because of small sample sizes and varied study designs among different studies. We performed a meta-analysis to assess this correlation. A comprehensive search was conducted to ... more

P.Y. Hu; Y.W. Wang; X.H. Pang; H.W. Wang
Meta-analysis; Myocardial infarction; Polymorphism; TNF-β

Tumor necrosis factor-β (TNF-β) is an important mediator of inflammation and may play a role in the pathogenesis of myocardial infarction (MI). While several published studies have investigated the association between the C804A polymorphism in the TNF-β gene and MI risk, their results are controversial and ambiguous. In this study, we evaluated the contribution of the ... more

D.W. Suo; Q. Hu; J. Chen; Q.H. Sun; H. Guo
B-type natriuretic peptide; Cirrhosis; Clinical outcome

Brain natriuretic peptide (BNP) is used as a marker of cardiac dysfunction to predict heart failure mortality. The significance of the prognostic ability of BNP for liver cirrhosis remains unknown, although the levels of BNP seen in cirrhosis are high. We aimed to determine whether the BNP level is related to the stage of cirrhosis and could serve as a prognostic marker of cirrhosis ( ... more

L.Y. Shi; R. Jin; C.J. Lin; J.S. Wu; X.W. Chen; Z. Yu; P.C. Zhang